Kedaara Capital makes a quiet exit. Did it make any money?
Private equity firm Kedaara Capital has sold its stake in a pharmaceutical company, marking its exit from the sector. The firm's exit, which hasn't been formally announced, occurred shortly before Kedaara reached its 10-year mark as a fund and raises questions about the profits made from the investment.